Literature DB >> 7959284

Recurrent cytogenetic aberrations and loss of constitutional heterozygosity in ovarian carcinomas.

M Kiechle-Schwarz1, T Bauknecht, U Karck, F Kommoss, A du Bois, A Pfleiderer.   

Abstract

Cancer is regarded as the result of the accumulation of multiple genetic changes leading to either the activation of oncogenes and increased expression of mitogenic pathways or the inactivation of tumor suppressor genes. It was our interest to investigate malignant ovarian tumors with cytogenetic and molecular techniques to evaluate their consistent genetic alterations. Cytogenetic analysis was performed on 30 short-term cultured ovarian carcinomas. Fifteen tumors revealed clonal cytogenetic abnormalities, 10 of which had very complex karyotypes. The most consistent finding was a 19p+ marker chromosome which was present in half of the cytogenetically abnormal tumors with complex chromosome aberrations. Four tumors showed structural rearrangements resulting in loss of 11p13-pter material. Parallel DNA extracts from 18 tumor samples and corresponding normal white blood cells were analyzed by Southern blotting using 4 polymorphic probes spanning the region 11p15.1 to 11p15.5 and one polymorphic probe mapped to 19p13. Regarding the 11p probes, reduction to homozygosity in the tumor DNA was found in 9 of 17 informative cases. Loss of 19p alleles was found in 5 of 13 informative tumors. Our findings suggest that tumor suppressor genes located on the short arms of chromosomes 11 and 19 are involved in the development of human ovarian cancer.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7959284     DOI: 10.1006/gyno.1994.1277

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


  4 in total

1.  A 7.5 Mb sequence-ready PAC contig and gene expression map of human chromosome 11p13-p14.1.

Authors:  B Gawin; A Niederführ; N Schumacher; H Hummerich; P F Little; M Gessler
Journal:  Genome Res       Date:  1999-11       Impact factor: 9.043

2.  Isolation and characterization of p19INK4d, a p16-related inhibitor specific to CDK6 and CDK4.

Authors:  K L Guan; C W Jenkins; Y Li; C L O'Keefe; S Noh; X Wu; M Zariwala; A G Matera; Y Xiong
Journal:  Mol Biol Cell       Date:  1996-01       Impact factor: 4.138

Review 3.  Molecular characterisation and expression analysis of SEREX-defined antigen NUCB2 in gastric epithelium, gastritis and gastric cancer.

Authors:  Z Kalnina; K Silina; R Bruvere; N Gabruseva; A Stengrevics; S Barnikol-Watanabe; M Leja; A Line
Journal:  Eur J Histochem       Date:  2009-03-31       Impact factor: 3.188

4.  Involvement of DPP9 in gene fusions in serous ovarian carcinoma.

Authors:  Marianne Lislerud Smebye; Antonio Agostini; Bjarne Johannessen; Jim Thorsen; Ben Davidson; Claes Göran Tropé; Sverre Heim; Rolf Inge Skotheim; Francesca Micci
Journal:  BMC Cancer       Date:  2017-09-11       Impact factor: 4.430

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.